je.st
news
Tag: gileads
Gilead's new HIV drug shows lower side-effects over longer term
2015-10-22 16:09:33| Biotech - Topix.net
Drugmaker Gilead Sciences Inc said data from a late-stage study showed that its experimental drug, Genvoya, showed reduced side-effects compared with an older version of the drug in treating HIV-infected patients over a longer term. The company said Genvoya was as good as Stribild, which is the older version, after 96 weeks of treatment and had lesser side-effects on patients' kidneys and bones.
Premarket Biotech Digest: Gilead's Upcoming Earnings, Setback For AstraZeneca, Zafgen Tumbles 50%
2015-10-19 16:04:07| Biotech - Topix.net
The consensus forecast for Q3 revenue is at $7.81 billion, which is below the $8.24 billion reported in the previous quarter. The slight decline in revenue is due to a slowdown in the U.S. Hep C sales.
Tags: upcoming
earnings
digest
biotech
Premarket Biotech Digest: Understanding Multiple Sclerosis, Gilead's...
2015-10-12 22:32:16| Biotech - Topix.net
I remember, somewhere in my academic days or probably from cursory reading, I did some readings on what Western philosophers call "personhood." Well, the idea that the human body is not innately intelligent becomes obvious to me when I consider cancer, and immunosuppressive disorders like multiple sclerosis, or MS.
Tags: multiple
understanding
digest
biotech
Premarket Biotech Digest: Gilead's Genvoya, Avelumab Granted ODD, Bellerophon Rallies
2015-09-28 17:27:51| Biotech - Topix.net
Breast cancer is not a single disease, but literally more than a hundred types of diseases and conditions. Breast cancer varies so much because it can be caused by more than one type of cell in the breast.
Tags: granted
odd
digest
biotech
Premarket Biotech Digest: Hillary's Tweet, Arrowhead Investor Day, Gilead's HCV Success
2015-09-22 17:02:28| Biotech - Topix.net
A left-leaning tweet from Democratic Presidential candidate Hillary Clinton sent biotech stocks spiraling downwards yesterday, providing an opportunity for us poor investors to buy a few good price-gouging stocks at the dip. Hillary promises more biotech attack today, so watch out for further opportunities.
Tags: day
success
investor
digest